Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastroenteropancreatic Neuroendocrine Tumors
×
Temozolomide
×
Endocrine
×
Clear all
Filters
3
NCT02231762
2019-05-06
SONNET
Ipsen
Phase 2
Completed
57 enrolled
20 charts